James Rowden v. HHS - DTaP, Guillain-Barre Syndrome (GBS) and Acute Inflammatory Demyelinating Polyneuropathy (AIDP) (2016)

James Rowden filed a petition for compensation under the National Vaccine Injury Compensation Program on May 9, 2014, alleging that he developed Guillain-Barre Syndrome (GBS) and Acute Inflammatory Demyelinating Polyneuropathy (AIDP) as a result of receiving multiple vaccinations on or about September 25, 2013. The vaccines included DTaP, Menactra, polio, Hepatitis A, Hepatitis B, and influenza.

Respondent denied that these vaccinations caused Mr. Rowden's alleged injuries.

Despite the denial, the parties reached a joint stipulation to settle the case. The stipulation, filed on September 12, 2016, outlined the terms of the settlement.

As part of the agreement, the respondent agreed to issue a payment of $1,887,733.63 to Mr. Rowden and to purchase an annuity contract for additional compensation.

The Special Master adopted the stipulation and awarded compensation in the agreed-upon amount and terms. The clerk of the court was directed to enter judgment accordingly.